Takeda Pharmaceutical (TAK) Scheduled to Post Earnings on Thursday

Takeda Pharmaceutical (NYSE:TAK) is scheduled to announce its earnings results before the market opens on Thursday, October 31st. Analysts expect the company to announce earnings of $0.39 per share for the quarter. Takeda Pharmaceutical has set its FY 2024 guidance at 2.770-2.770 EPS.

Takeda Pharmaceutical (NYSE:TAK) last posted its earnings results on Wednesday, July 31st. The company reported $0.56 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.37 by $0.19. The company had revenue of $7.75 billion for the quarter. Takeda Pharmaceutical had a return on equity of 10.11% and a net margin of 6.02%. On average, analysts expect Takeda Pharmaceutical to post $2 EPS for the current fiscal year and $2 EPS for the next fiscal year.

Takeda Pharmaceutical Stock Performance

TAK stock opened at $13.86 on Thursday. The firm has a 50-day simple moving average of $14.61 and a two-hundred day simple moving average of $13.77. The company has a debt-to-equity ratio of 0.65, a quick ratio of 0.74 and a current ratio of 1.26. Takeda Pharmaceutical has a one year low of $12.57 and a one year high of $15.08. The firm has a market cap of $43.86 billion, a price-to-earnings ratio of 25.20, a PEG ratio of 0.27 and a beta of 0.54.

Takeda Pharmaceutical Company Profile

Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived therapies, immunology, oncology, and neuroscience.